| Identification | Back Directory | [Name]
1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one | [CAS]
23141-25-5 | [Synonyms]
Strictosamide
strictosidinelactam
(15β)-19,20-Didehydro-16α-ethenyl-17β-(β-D-glucopyranosyloxy)-18-oxayohimban-21-one
1,2,7,8,13,13bβ,14,14aα-Octahydro-1β-vinyl-2α-(β-D-glucopyranosyloxy)-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one
(1R)-1β-Ethenyl-2α-(β-D-glucopyranosyloxy)-1,2,7,8,13,13bβ,14,14aα-octahydro-5H-indolo[2,3-a]pyrano[3,4-g]quinolizine-5-one
5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one,1-ethenyl-2-(b-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-,(1R,2S,13bS,14aS)-
5H-Indolo[2,3-a]pyrano[3,4-g]quinolizin-5-one, 1-ethenyl-2-(β-D-glucopyranosyloxy)-1,2,7,8,13,13b,14,14a-octahydro-, (1R,2S,13bS,14aS)- | [Molecular Formula]
C26H30N2O8 | [MDL Number]
MFCD14105616 | [MOL File]
23141-25-5.mol | [Molecular Weight]
498.53 |
| Chemical Properties | Back Directory | [Melting point ]
176-177 °C(Solv: methanol (67-56-1)) | [Boiling point ]
816.2±65.0 °C(Predicted) | [density ]
1.53±0.1 g/cm3(Predicted) | [storage temp. ]
4°C, protect from light | [solubility ]
DMSO : 100 mg/mL (200.59 mM; Need ultrasonic) | [form ]
Solid | [pka]
12.79±0.70(Predicted) | [color ]
Off-white to yellow |
| Hazard Information | Back Directory | [Uses]
Strictosamide has important effects on inflammation and inflammatory pain. Strictosamide possesses antiplasmodial and antifungal activities[1]. | [Definition]
ChEBI: Strictosamide is a member of beta-carbolines. | [IC 50]
Plasmodium | [storage]
4°C, protect from light | [References]
[1] Na Li, et al. In vivo anti-inflammatory and analgesic activities of strictosamide from Nauclea officinalis. Pharm Biol. 2014 Nov;52(11):1445-50. DOI:10.3109/13880209.2014.895910 |
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
|